65 and older, any sex, with Anatomic Stage I Breast Cancer AJCC v8 or Anatomic Stage II Breast Cancer AJCC v8. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Physical Function at End-of-interventionPrimary· end-of-intervention, at 12 weeks
Measured by the Short Physical Performance Battery (SPPB) score. The SPPB score is a continuous variable, collected as the total score ranging from 0-12, higher scores denote higher physical function. Values reported are at the end-of-intervention.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
9.2
± 2.2
Arm 2 (educational materials)
9.1
± 2.3
Satisfaction of the Delivery Method and Information Provided by Nutrition and Exercise Counseling SessionsSecondary· end-of-intervention, at 12 weeks
Percentage of participant satisfaction ("satisfied" and "very satisfied") measured by a 5-item Likert-scale questionnaire. Scores range from 1-5, with 5 being the highest score of satisfaction.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
5
1 – 5
Arm 2 (educational materials)
5
1 – 5
Study Accrual RateSecondary· assessed during the 12 month recruitment period
Will be calculated by dividing the number of potential participants that passed screening by the total number of participants started in the study after appropriate informed consent procedures.
Group
Value
95% CI
All potential participants
23.1
Study Retention RateSecondary· End-of-study, up to 3 months
calculated by dividing the total number of participants initiated by total number of participants in the study. Retention goal for this trial is 80%. If 80% (56/70) of participants are retained at end-of-study, the retention goal for this trial will be achieved. Overall retention rates and associated 95% confidence intervals will be reported.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
30
Arm 2 (educational materials)
33
Study Adherence RateSecondary· end-of-intervention, at 12 weeks
Participants were determined to be adherent if they attend \>= 80% of the online intervention sessions. Overall adherence rates and associated 95% confidence intervals were reported.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
97
Arm 2 (educational materials)
95
Grip StrengthSecondary· end-of-intervention, at 12 weeks
Handgrip strength (absolute value at the end of the intervention) was measured in both hands using a hydraulic grip strength dynamometer. This is measured in kgs.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
28.6
± 5.2
Arm 2 (educational materials)
28.3
± 4.8
Dietary QualitySecondary· end-of-intervention, at 12 weeks
Dietary quality was assessed by the National Cancer Institute's Diet History Questionnaire III using the Healthy Eating Index score ranging 0-100, with higher scores meaning higher diet quality. Absolute value at end-of-intervention was assessed using the Healthy Eating Index score.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
69.3
63 – 76
Arm 2 (educational materials)
68.1
61 – 75
Percentage of Participants Who Completed Resistance ExercisesSecondary· end-of-intervention, at 12 weeks
Self-reported resistance exercise (% yes) was assessed using the revised version of The Godin-Shephard Leisure-Time Exercise Questionnaire modified to specifically capture self-reported resistance exercise participation. If a participant denoted "yes" to the question: did During a typical 7-Day period (a week), did you participate in resistance exercise for more than 15 minutes during your free time? Percentages denote the percentage of the study subjects who participated in resistance training at end of intervention.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
97
Arm 2 (educational materials)
65
Health-related Quality of Life (HRQoL)Secondary· end-of-intervention, at 12 weeks
RAND-36 Health Status Measure is comprised of 36 items which automatically create 8 subscales assessing multiple aspects of HRQoL. All scores range from 0-100, with 100 as the highest HRQoL. The main HRQoL subscale reported is the general health HRQoL subscale. Mean scores of general HRQoL for end-of-intervention are reported.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
53.8
± 18.9
Arm 2 (educational materials)
60.1
± 19.1
Self-efficacySecondary· end-of-intervention, at 12 weeks
Self-efficacy was measured at the end of intervention via a 0-10 confidence scale rating the confidence of making exercise and diet changes in one's life, with 0 meaning not confident, 10 meaning very confident.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
9.47
± 2.1
Arm 2 (educational materials)
8.97
± 1.9
Technology CompetencySecondary· end-of-intervention, at 12 weeks
The 8-item eHealth Literacy Scale measured knowledge, comfort, and perceived skills of engaging in eHealth at end-of-intervention. A 5-point Likert scale was used, with possible scores ranging from 8 to 40. Higher scores indicate higher ehealth literacy.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
33.9
27 – 40
Arm 2 (educational materials)
33.2
26 – 40
Anthropometry Body Weight in KilogramsSecondary· end-of-intervention, at 12 weeks
At end-of-intervention, participant's body weight was assessed in kilograms.
Group
Value
95% CI
Arm 1 (nutritional counseling, resistance training)
28
26 – 32
Arm 2 (educational materials)
29
24 – 33
Sponsor's own description
This phase I trial tests the feasibility, acceptability, and preliminary effectiveness of online dietary and resistance training to improve physical function in older (greater than or equal to 65-years old) cancer survivors. Declines in adequate protein and calorie intake results in faster loss of muscle mass and physical functioning in older adults. A novel approach to improving physical function in older cancer survivors (OCS) is to utilize online, tailored education and counseling from registered dietitians and exercise scientists, to improve dietary intake (protein intake, diet quality) and participation in resistance exercise. The purpose of this study is to help researchers learn whether an online dietary and resistance training intervention improves diet, exercise, physical function, and health outcomes in OCS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
· NA
· not yet recruiting
NCT06565260 — Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
· NA
· recruiting
NCT07302230 — Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Amon
· NA
· recruiting
NCT07340281 — Biomarkers for Exercise
· NA
· recruiting
NCT07504835 — GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
· NA
· not yet recruiting
Other recruiting trials for Anatomic Stage I Breast Cancer AJCC v8
Currently open trials in the same condition.
NCT07443943 — A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive
· Phase 2
· recruiting
NCT07158021 — Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
· Phase 2
· recruiting
NCT06324240 — Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Canc
· Phase 1
· recruiting
NCT07407920 — Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
· Phase 2
· active not recruiting
NCT06876714 — ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
· Phase 3
· recruiting
Other Ohio State University Comprehensive Cancer Center trials
Trials by the same sponsor.
NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell
· NA
· not yet recruiting
NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts
· Phase 2
· not yet recruiting
NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer
· NA
· not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
· Phase 1, PHASE2
· not yet recruiting
NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health
· Phase 4
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
Last refreshed: 2 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06016725.